WallStSmart
LSTA

Lisata Therapeutics Inc.

NASDAQ: LSTA · HEALTHCARE · BIOTECHNOLOGY

$3.12
-3.11% today

Updated 2026-04-30

Market cap
$28.18M
P/E ratio
P/S ratio
165.77x
EPS (TTM)
$-1.91
Dividend yield
52W range
$2 – $5
Volume
0.1M

Lisata Therapeutics Inc. (LSTA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-3.64M$-6.13M$-4.73M$-8.65M$-8.48M$-20.93M$-13.85M$-27.10M$-46.90M$-39.26M$-23.67M$-20.88M$-19.99M$-18.88M$-8.82M$-22.25M$-21.17M$-20.03M$-19.36M$-15.95M
Capital expenditures$43136.00$117893.00$9785.00$2.39M$16.38M$574857.00$531315.00$2.69M$3.66M$3.19M$2.85M$135281.00$134000.00$20000.00$20000.00$60000.00$285000.00$0.00$0.00$28000.00
Depreciation
Stock-based comp$4.59M$3.89M$12.32M$7.86M$10.27M$6712.00$6.84M$11209.00$9750.00$2.60M$1.96M$2.45M$1.29M$1.26M$2.00M$2.64M$2.04M$1.65M$1.23M
Free cash flow$-3.68M$-6.25M$-4.74M$-11.04M$-24.85M$-21.50M$-14.38M$-29.79M$-50.55M$-42.44M$-26.52M$-21.01M$-20.12M$-18.90M$-8.84M$-22.30M$-21.45M$-20.03M$-19.36M$-15.98M
Investing cash flow
Financing cash flow
Dividends paid$222924.00$2.89M$327748.00$15.00M
Share repurchases
Debt repayment
Net change in cash